[News Brief] Samsung Bioepis Launches Ustekinumab Biosimilar in Japan
Samsung Bioepis, a South Korea-based company, has launched its ustekinumab biosimilar in Japan through its partnership with Nipro Corporation, expanding…
Samsung Bioepis, a South Korea-based company, has launched its ustekinumab biosimilar in Japan through its partnership with Nipro Corporation, expanding…
South Korea-based Hyundai Bioscience has announced its readiness to supply its broad-spectrum antiviral drug XAFTY® in the event of Ebola…
Australia’s Therapeutic Goods Administration (TGA) has approved the OncoSil™ medical device for use in patients with locally advanced pancreatic cancer.…
Lotus Pharmaceutical, a Taiwan-based company, has entered into an agreement with OM Pharma to acquire the assets of a specialty…
China’s National Medical Products Administration (NMPA) has issued new implementation measures formalising protection for eligible undisclosed drug trial data submitted…
Suzhou Ribo Life Science Co., Ltd. and Insilico Medicine have entered into a strategic collaboration to integrate artificial intelligence platforms…
Agilent Technologies and Singapore’s Nucleic Acid Therapeutics Initiative (NATi) have entered a two-year research collaboration to advance analytical workflows for…
Medtec China 2026, a medical device manufacturing trade exhibition, will be held at the Shanghai New International Expo Centre, bringing…
HKSH Medical Group and Siemens Healthineers have signed a collaboration agreement designating HKSH as the first Photon-Counting Computed Tomography Simulator…
AstraZeneca and Roche Diagnostics Asia Pacific have signed a three-year Memorandum of Understanding to support the development of digital and…